PGAP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.196400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.916400E-01
Normal-vs-Stage2
5.811000E-01
Normal-vs-Stage3
5.079400E-01
Normal-vs-Stage4
1.489560E-01
Stage1-vs-Stage2
3.492600E-01
Stage1-vs-Stage3
1.843420E-01
Stage1-vs-Stage4
7.259400E-01
Stage2-vs-Stage3
2.529800E-01
Stage2-vs-Stage4
1.927960E-01
Stage3-vs-Stage4
4.337700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.104200E-01
Normal-vs-AfricanAmerican
3.347200E-01
Normal-vs-Asian
9.510800E-01
Caucasian-vs-AfricanAmerican
4.908600E-01
Caucasian-vs-Asian
1.814450E-01
AfricanAmerican-vs-Asian
1.518190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.983000E-01
Normal-vs-Female
5.321400E-01
Male-vs-Female
3.521800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.496300E-02
Normal-vs-Age(41-60Yrs)
3.352600E-01
Normal-vs-Age(61-80Yrs)
5.976400E-01
Normal-vs-Age(81-100Yrs)
7.285400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.038630E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.58450000001353E-06
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.77539999999654E-05
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.037500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.524240E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.875500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.506800E-01
Normal-vs-Daily Drinker
8.862200E-01
Normal-vs-Weekly Drinker
8.599600E-01
Normal-vs-Occasional Drinker
2.181400E-01
Normal-vs-Social Drinker
6.512600E-01
Non Drinker-vs-Daily Drinker
9.605000E-01
Non Drinker-vs-Weekly Drinker
9.897000E-01
Non Drinker-vs-Occasional Drinker
1.516360E-02
Non Drinker-vs-Social Drinker
4.703600E-01
Daily Drinker-vs-Weekly Drinker
9.770800E-01
Daily Drinker-vs-Occasional Drinker
1.463550E-02
Daily Drinker-vs-Social Drinker
4.390600E-01
Weekly Drinker-vs-Occasional Drinker
3.168100E-02
Weekly Drinker-vs-Social Drinker
5.024800E-01
Occasional Drinker-vs-Social Drinker
1.996210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.517050E-01
Normal-vs-Grade 2
1.187990E-01
Normal-vs-Grade 3
1.361820E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.386980E-01
Grade 1-vs-Grade 3
1.451610E-01
Grade 1-vs-Grade 4
1.517050E-01
Grade 2-vs-Grade 3
9.146600E-01
Grade 2-vs-Grade 4
1.187990E-01
Grade 3-vs-Grade 4
1.361820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.252200E-01
Normal-vs-NonDiabetic
6.034600E-01
Diabetic-vs-NonDiabetic
6.005800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.262400E-01
Normal-vs-NoPancreatitis
5.462000E-01
Pancreatitis-vs-NoPancreatitis
4.995000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.814400E-01
Normal-vs-N1
5.700400E-01
N0-vs-N1
2.434000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.407200E-01
Normal-vs-TP53-NonMutant
3.151600E-01
TP53-Mutant-vs-TP53-NonMutant
1.993670E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
